ConductScience.org, home
FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies.
API referenceFor AI assistants

Paper · 35176457

Cited by119

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 172 citations.

1 to 20 of 119

Download this page as JSON
PMIDTitleJournalYearIn PapersSource
42,827,286A Real-World Study of Patients with FGFR-Altered Advanced Solid Tumors after Exhaustion of Standard-of-Care Treatment.Cancer Res Commun2026https://conductscience.org/library/papers/42827286PubMed
42,542,997FGF/FGFR Alteration Type as a Candidate Enrichment Biomarker for Gunagratinib in Recurrent or Metastatic Head and Neck Cancer: An Exploratory Analysis of Two Early-Phase Trials.Target Oncol2026https://conductscience.org/library/papers/42542997PubMed
42,406,058The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials.Cancer Chemother Pharmacol2026https://conductscience.org/library/papers/42406058PubMed
42,177,363FGFR3 oncogenic activation drives oxidative metabolic reprogramming in bladder cancer: a systems metabolomics approach.Commun Biol2026https://conductscience.org/library/papers/42177363PubMed
42,146,765Research on Targeted Therapy for Malignant Tumors of the Biliary Tract.Onco Targets Ther2026https://conductscience.org/library/papers/42146765PubMed
42,087,217Comprehensive molecular characterization identifies therapeutic vulnerabilities in ovarian clear cell carcinoma.Genome Med2026https://conductscience.org/library/papers/42087217PubMed
41,799,559Holistic Treatment Incorporating Moist Wound Healing for Postoperative Radiation-Induced Perineal Ulcer in Rectal Malignancy: A Case Report.Case Rep Dermatol2026https://conductscience.org/library/papers/41799559PubMed
41,773,262Fibroblast Growth Factor Receptor (FGFR) Inhibitors for the Treatment of Cholangiocarcinoma: Key Therapeutic Developments and Knowledge Gaps.Drug Des Devel Ther2026https://conductscience.org/library/papers/41773262PubMed
41,764,695Ligand-based graph neural network, molecular dynamics and biological evaluation for identification of potential FGFR1 kinase inhibitors.Mol Divers2026https://conductscience.org/library/papers/41764695PubMed
41,646,477A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in pancreatic cancer.ESMO Gastrointest Oncol2025https://conductscience.org/library/papers/41646477PubMed
41,514,604FGFR Aberrations in Solid Tumors: Mechanistic Insights and Clinical Translation of Targeted Therapies.Cancers (Basel)2025https://conductscience.org/library/papers/41514604PubMed
41,370,732Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia.JCO Precis Oncol2025https://conductscience.org/library/papers/41370732PubMed
41,361,008Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations.Nat Genet2026https://conductscience.org/library/papers/41361008PubMed
41,226,789Expanding Horizons in Cholangiocarcinoma: Emerging Targets Beyond FGFR2 and IDH1.Int J Mol Sci2025https://conductscience.org/library/papers/41226789PubMed
41,174,249Concurrence of FGFR1 mutations modulates oncogenesis in glioneuronal tumors.EMBO J2025https://conductscience.org/library/papers/41174249PubMed
41,166,678Clinical Utility of Whole-Genome Sequencing to Aid Histologic Diagnosis and to Direct Personalized Medicine in Salivary Gland Cancer.JCO Precis Oncol2025https://conductscience.org/library/papers/41166678PubMed
41,143,603PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.Clin Cancer Res2026https://conductscience.org/library/papers/41143603PubMed
40,977,663Fibroblast growth factor 19-fibroblast growth factor receptor 4 axis: From oncogenesis to targeted-immunotherapy in advanced hepatocellular carcinoma.World J Gastrointest Oncol2025https://conductscience.org/library/papers/40977663PubMed
40,847,555Persistent lineage plasticity driving lung cancer development and progression.Clin Transl Med2025https://conductscience.org/library/papers/40847555PubMed
40,834,499FGFR1-amplified colorectal cancer: a distinct prognostic subtype identified through integrated genomic and immunohistochemical profiling.ESMO Open2025https://conductscience.org/library/papers/40834499PubMed

papers-2026-11-12-0.1.0

Next page

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/35176457/cited_by

API referenceFor AI assistants